PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of bmjcredLink to Publisher's site
 
Br Med J (Clin Res Ed). 1985 April 27; 290(6477): 1246–1248.
PMCID: PMC1415890

Controlled study of withdrawal symptoms and rebound anxiety after six week course of diazepam for generalised anxiety.

Abstract

A group of patients suffering from anxiety, as assessed by general practitioners and psychologists using research criteria for generalised anxiety, were treated with either diazepam or placebo double blind for six weeks. This active treatment period was preceded by a one week single blind placebo "wash in" period and followed by a two week single blind placebo "wash out" period. The results suggest that diazepam can produce rebound anxiety and withdrawal symptoms when used in moderate doses and for what has previously been regarded as a safe length of time. If replicated these results have implications for the therapeutic use of benzodiazepines.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (667K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Skegg DC, Doll R, Perry J. Use of medicines in general practice. Br Med J. 1977 Jun 18;1(6076):1561–1563. [PMC free article] [PubMed]
  • Shapiro AK, Struening EL, Shapiro E, Milcarek BI. Diazepam: how much better than placebo? J Psychiatr Res. 1982;17(1):51–73. [PubMed]
  • Tyrer PJ. Benzodiazepines on trial. Br Med J (Clin Res Ed) 1984 Apr 14;288(6424):1101–1102. [PMC free article] [PubMed]
  • Pesce A, Rossi F, Valeri P. Effetti collaterali delle benzodiazepine: l'ansia e l'insonnia di "rimbalzo". Clin Ter. 1981 Dec 15;99(5):461–470. [PubMed]
  • Hallstrom C, Lader M. Benzodiazepine withdrawal phenomena. Int Pharmacopsychiatry. 1981;16(4):235–244. [PubMed]
  • Tyrer P, Owen R. Anxiety in primary care: is short-term drug treatment appropriate? J Psychiatr Res. 1984;18(1):73–78. [PubMed]
  • Miller F, Nulsen J. Single case study. Diazepam (Valium) detoxification. J Nerv Ment Dis. 1979 Oct;167(10):637–638. [PubMed]
  • de Bard ML. Diazepam withdrawal syndrome: a case with psychosis, seizure, and coma. Am J Psychiatry. 1979 Jan;136(1):104–105. [PubMed]
  • Petursson H, Lader MH. Withdrawal from long-term benzodiazepine treatment. Br Med J (Clin Res Ed) 1981 Sep 5;283(6292):643–645. [PMC free article] [PubMed]
  • Fontaine R, Chouinard G, Annable L. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. Am J Psychiatry. 1984 Jul;141(7):848–852. [PubMed]
  • Winokur A, Rickels K, Greenblatt DJ, Snyder PJ, Schatz NJ. Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study. Arch Gen Psychiatry. 1980 Jan;37(1):101–105. [PubMed]
  • HAMILTON M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55. [PubMed]
  • Kellner R, Sheffield BF. A self-rating scale of distress. Psychol Med. 1973 Feb;3(1):88–100. [PubMed]
  • Owen RT, Tyrer P. Benzodiazepine dependence. A review of the evidence. Drugs. 1983 Apr;25(4):385–398. [PubMed]

Articles from British Medical Journal (Clinical Research Ed.) are provided here courtesy of BMJ Publishing Group